$6.18
-0.01-0.16%
Last update: Oct 26, 8:24 AM
Precigen Inc (PGEN) Stock Price, Quote, News & History
PGENNASDAQ
Precigen submits BLA for PRGN-2012 gene therapy targeting RRP, a rare and life-threatening condition with no cure.
You can purchase shares of Precigen (NASDAQ:PGEN) through any online brokerage.
Other companies in Precigen’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Precigen has a consensus price target of $10.14.
The stock price for Precigen (NASDAQ: PGEN) is $6.18 last updated October 26, 2026 at 8:24 AM EDT.
There are no upcoming dividends for Precigen.
Precigen does not have any upcoming earnings scheduled.
There is no upcoming split for Precigen.
Precigen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary...
